Streetbeat News

Revenues

BWMN

Bowman Consulting Group Ltd. (BWMN) has acquired Hess-Rountree, Inc., a Phoenix-based full-service engineering firm. The acquisition is expected to operate at an annualized net service billing run rate of approximately $3 million. Hess-Rountree specializes in civil engineering, land surveying, and other services, with a focus on renewable energy and educational facilities. The acquisition, financed with cash, seller notes, and equity, aligns with Bowman's strategic growth objectives and is expected to be immediately accretive.

Portfolio Pulse from Benzinga Newsdesk

December 12, 2023 | 1:10 pm

EDAP

EDAP TMS SA announced that the French National Authority for Health (HAS) has issued a favorable recommendation for the reimbursement of its high-intensity focused ultrasound (HIFU) therapy for prostate cancer treatment. This is a significant step towards securing final reimbursement in France.

Portfolio Pulse from Benzinga Newsdesk

December 12, 2023 | 1:06 pm

EKSO

Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) announced CMS approval for HCPCS Code K1007 to bill Medicare for Ekso Indego Personal, an exoskeleton for individuals with spinal cord injuries. CMS proposed a payment of $94,617 for devices under this code, with a final decision expected in February 2024. The code will take effect on April 1, 2024. The approval is seen as an inflection point for the device, expected to improve health outcomes and quality of life for SCI patients. Ekso presented at the HCPCS public meeting, emphasizing the device's benefits, and received support from Dr. Alberto Esquenazi, who noted the clinical benefits of Ekso devices in rehabilitation.

Portfolio Pulse from Benzinga Newsdesk

December 12, 2023 | 1:06 pm

MRNA

Moderna, Inc. (NASDAQ:MRNA) is restructuring its operating model to prioritize sales of its COVID-19 vaccine, Spikevax, and the upcoming launch of its RSV vaccine in 2024. CEO Stephane Bancel will take charge of sales and marketing, while President Stephen Hoge will oversee pipeline commercial strategy and Medical Affairs. Arpa Garay, the outgoing Chief Commercial Officer, will advise during the transition before leaving the company.

Portfolio Pulse from Benzinga Newsdesk

December 12, 2023 | 1:06 pm

ADV

Advantage Solutions is restructuring its international businesses to reduce complexities and expenses, simplify financial reporting, and eliminate losses in some Asian businesses. The company also plans to trade a minority interest in a foreign business for shares of Advantage stock.

Portfolio Pulse from Benzinga Newsdesk

December 12, 2023 | 1:02 pm

STRM

Streamline Health Solutions has broadened its existing agreement with a five-hospital health system in Pennsylvania, integrating eValuator's Pro-Fee pre-bill coding analysis technology to enhance revenue integrity and financial performance for professional fee services.

Portfolio Pulse from Benzinga Newsdesk

December 12, 2023 | 12:35 pm

FCEL

HAS

JCI

LCID

ORCL

QQQ

SPY

U.S. stock futures, including Nasdaq and S&P 500, are up ahead of the November consumer price inflation report. A softer inflation reading could prompt a rally if it aligns with expectations for a less hawkish Federal Reserve. Despite positive market performance on Monday, corporate updates have been negative, potentially affecting sector stocks. SPDR S&P 500 ETF Trust (SPY) and Invesco QQQ ETF (QQQ) saw premarket gains. Lucid Group (LCID) dropped after its CFO's resignation, Oracle (ORCL) slumped following quarterly results, and Hasbro (HAS) declined after announcing job cuts. FuelCell Energy (FCEL) and Johnson Controls (JCI) are set to report earnings.

Portfolio Pulse from Shanthi Rexaline

December 12, 2023 | 12:25 pm

CCCC

MRK

C4 Therapeutics (CCCC) has entered into a license and research collaboration with Merck (MRK) to develop degrader-antibody conjugates. C4T will receive an upfront payment of $10 million and is eligible for milestone payments that could total up to $600 million.

Portfolio Pulse from Benzinga Newsdesk

December 12, 2023 | 12:03 pm

CJET

DLA

FSR

MNSO

YUMC

The article highlights the top 5 oversold consumer discretionary stocks with an RSI near or below 30, suggesting potential undervaluation. Chijet Motor Company (CJET) reported a significant revenue drop and its stock fell 39% over five days. Yum China Holdings (YUMC) missed revenue consensus, with a 10% stock decline over a month. MINISO Group (MNSO) reported strong revenue growth but experienced a 25% stock decrease over a month. Delta Apparel (DLA) posted downbeat sales and a 21% stock loss over five days. Fisker Inc. (FSR) announced new hires but saw a 63% stock fall over a month.

Portfolio Pulse from Avi Kapoor

December 12, 2023 | 11:46 am

FXI

China is accelerating the development of a new real estate model, aiming to balance local debt risks and ensure stable growth, as reported by Reuters citing state media.

Portfolio Pulse from Charles Gross

December 12, 2023 | 11:26 am